CD8A and cancer: The M2 subtype had the most favorable prognosis, suggesting that the CD8‐positive response and an increase in B‐cell infiltrates are needed for cancer control, consistent with previous reports.27, 28, 29 In contrast, the M3 subtype conferred the worst prognosis and displayed composite signatures reflecting immunosuppression response, leukocyte migration, and so on.